Clinical Study on Efficacy of Internal and External Linkage of the Osteoking on the Treatment of Knee Osteoarthritis with Qizhi Xueyu Syndrome
Objective:To observe the clinical efficacy of osteoking on the treatment of knee osteoarthritis with Qizhi Xueyu syndrome.Methods:120 patients with Qizhi Xueyu syndrome knee osteoarthritis from September 2022 to September 2023 were collected and divided into combination group,drug dialysis group,oral group and control group according to random number table method,with 30 cases in each group.In the combination group,osteoking was given orally combined with traditional Chinese medicine(TCM)directional penetration therapy;in the drug dialysis group,osteoking was treated with directional drug penetration treatment;in the oral group,osteoking was given orally,and the control group was treated with celecoxib.12 d as one course of treatment and 2 courses of treatment.The clinical efficacy,visual analogue scale(VAS)scores,Western Ontario and McMaster Universities(WOMAC)scores,TCM syndrome scores,36-Item Short Form Health Survey(SF-36)scores,and the level of inflammatory factors were observed before and after treatment in 4 groups.Results:There was no statistical difference in VAS scores,WOMAC scores,TCM syndrome scores,SF-36 scores and inflammatory factors among 4 groups before treatment(P>0.05).The VAS scores,WOMAC scores,TCM syndrome scores,SF-36 scores and inflammatory factors in combination group were better than those in control group,drug penetra-tion group and oral group after treatment(P<0.05).Conclusion:Osteoking has outstanding therapeutic efficacy on Qizhi Xueyu syndrome knee osteoarthritis,which can im-prove clinical symptoms,reduce the level of inflammatory factors and improve the quality of life of patients.
knee osteoarthritisQizhi Xueyu syndromeosteokingtraditional Chinese medicine directional penetra-tionboth internal and external treatment